Cargando…
A retrospective clinical audit of general practices in Australia to determine the motivation for switch to dolutegravir/abacavir/lamivudine and clinical outcomes
The most common reasons for switching HIV-1 therapy in patients with virologic suppression are treatment regimen simplification and resolving tolerability issues. Single-pill regimens that include an integrase inhibitor are recommended options. A retrospective clinical audit was performed to determi...
Autores principales: | Ferrer, Pedro E, Bloch, Mark, Roth, Norman, Finlayson, Robert, Baker, David, Koh, Ken, Orth, David, Urbaityte, Rimgaile, Brown, Dannae, Drummond, Fraser |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5794104/ https://www.ncbi.nlm.nih.gov/pubmed/28901212 http://dx.doi.org/10.1177/0956462417730474 |
Ejemplares similares
-
Combination dolutegravir–abacavir–lamivudine in the management of HIV/AIDS: clinical utility and patient considerations
por: Cruciani, Mario, et al.
Publicado: (2015) -
Clinical auditing to improve patient outcomes
por: Yorston, David, et al.
Publicado: (2010) -
An indirect comparison of efficacy and safety of elvitegravir/cobicistat/emtricitabine/tenofovir and dolutegravir + abacavir/lamivudine
por: Rogatto, Felipe, et al.
Publicado: (2014) -
Audit on Availability, Quality and Frequency of Clinical Supervision
por: Askew, Elizabeth, et al.
Publicado: (2022) -
Audit on the Quality of Outpatient Letters From Cherrywood Clinic
por: Akhtar, Armaan, et al.
Publicado: (2022)